Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients-Reference-Cited by-同舟云学术

Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients

Published:2021-03 Issue:2 Volume:45 Page:101460
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Chen Changyong,Qiu Huaiming,Yao Yuanhui,Zhang Zishu,Ma Cong,Ma Yilong,Zhao Chang,Xiang Hua,Zhao Hui,Zheng Chuansheng,Xiong Bin,Li Haiping,Long Qingyun,Zhou Jun,Luo Chao,Hu Hongyao

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference12 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2012

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

3. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

4. Efficacy and safety of cTACE versus DEB-TACE in patients with hepatocellular carcinoma: a meta-analysis;Zou;J Dig Dis,2016

5. Systematic review comparing the safety and efficacy of conventional and drug-eluting bead-transarterial chemoembolization for inoperable hepatocellular carcinoma;Xie;Hepatol Res,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the efficacy and safety of CalliSpheres® microsphere-transarterial chemoembolization in large hepatocellular carcinoma;Journal of Cancer Research and Therapeutics;2023-12

2. Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization;Journal of Hepatocellular Carcinoma;2023-10

3. Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma;Cancer Imaging;2023-02-22

4. Comparison of CalliSpheres^® microspheres drug-eluting beads and conventional transarterial chemoembolization in hepatocellular carcinoma patients: a randomized controlled trial;Radiology and Oncology;2023-02-17

5. Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-02